Everi Holdings Inc (EVRI)

Everi Holdings (EVRI) Income Statement


Everi Holdings Income Statement

Last quarter (Q3 2022), Everi Holdings's total revenue was $204.32M, an increase of 21.40% from the same quarter last year. In Q3, Everi Holdings's net income was $29.41M. See Everi Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 757.54M$ 660.38M$ 383.67M$ 533.23M$ 469.51M$ 974.95M
Cost of Revenue
$ 154.34M$ 115.45M$ 65.84M$ 112.39M$ 94.44M$ 638.54M
Gross Profit
$ 603.21M$ 544.94M$ 317.84M$ 420.84M$ 375.08M$ 336.40M
Operating Expense
$ 393.60M$ 347.43M$ 323.25M$ 326.82M$ 289.26M$ 254.58M
Operating Income
$ 209.61M$ 197.51M$ -5.42M$ 94.02M$ 85.81M$ 81.82M
Net Non Operating Interest Income Expense
$ -50.13M$ -62.10M$ -74.56M$ -77.84M$ -83.00M$ -102.14M
Other Income Expense
-$ -34.39M$ -7.46M$ -179.00K$ -166.00K$ -51.75M
Pretax Income
$ 159.48M$ 101.03M$ -87.44M$ 15.99M$ 2.65M$ -72.07M
Tax Provision
$ -23.40M$ -51.90M$ -5.76M$ -523.00K$ -9.71M$ -20.16M
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ 182.88M$ 152.93M$ -81.68M$ 16.52M$ 12.36M$ -51.90M
Basic EPS
$ 2.00$ 1.71$ -0.96$ 0.23$ 0.18$ -0.78
Diluted EPS
$ 1.82$ 1.53$ -0.96$ 0.21$ 0.17$ -0.78
Basic Average Shares
$ 364.20M$ 89.28M$ 85.38M$ 72.38M$ 69.46M$ 66.82M
Diluted Average Shares
$ 397.74M$ 99.97M$ 85.38M$ 79.23M$ 73.80M$ 66.82M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 547.93M$ 462.87M$ 389.09M$ 439.21M$ 383.70M$ 893.13M
Net Income From Continuing And Discontinued Operation
$ 182.88M$ 152.93M$ -81.68M$ 16.52M$ 12.36M$ -51.90M
Normalized Income
$ 182.88M$ 178.03M$ -74.72M$ 16.65M$ 12.48M$ -14.64M
Interest Expense
$ 209.61M$ 197.51M$ -5.42M$ 94.02M$ 85.81M$ 81.82M
$ 330.76M$ 316.99M$ 137.35M$ 234.86M$ 220.70M$ 206.43M
Currency in USD

Everi Holdings Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis